{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:18:06Z","timestamp":1785417486147,"version":"3.56.0"},"reference-count":108,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017034","name":"Health Technology Assessment international","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0266462326103912_sec1\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This systematic review explores which intersectoral costs and benefits (ICBs) are considered in the economic evaluation of pneumococcal conjugate vaccines (PCVs) across different age groups and the related impacts on the results of economic evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326103912_sec2\" sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seven databases were searched from 2009 to 2024 for full economic evaluations (Ees) of PCVs from a societal perspective. ICBs were presented narratively and in tabular form. Studies were appraised on quality, and PRISMA guidelines were followed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326103912_sec3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In all, 57 studies were included. ICBs were captured in the following sectors: patient and family, paid labor (productivity), nonpaid productivity, other sectors (education, leisure, consumption), unspecified sectors for ecological effects (herd immunity, serotype replacement, cross-protection), and equity. In cases where the comparator was no vaccination, 10 studies reported that PCVs were dominant when ICBs were included. After excluding dominant analyses, the median QALY-based incremental cost-effectiveness ratio (ICER) reduction ranged from \u22123.25 percent (for patient\/family costs and productivity loss) to \u221246.02 percent (in children with ecological effects). Among DALY-based studies, the inclusion of ecological effects reduced the median ICER by \u221222.97 percent. In head-to-head comparisons, 16 studies reported that PCVs were dominant when ICBs were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326103912_sec4\" sec-type=\"conclusions\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inclusion of ICBs, except for serotype replacement, showed favorable cost-effectiveness results. This study provides a framework for identifying the intersectoral costs and benefits for the health economic evaluation of PCVs in children and adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s0266462326103912","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:56:39Z","timestamp":1784296599000},"source":"Crossref","is-referenced-by-count":0,"title":["Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review"],"prefix":"10.1017","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-2726","authenticated-orcid":false,"given":"Emad","family":"Almomani","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jz4aj89","id-type":"ROR","asserted-by":"publisher"}],"name":"Maastricht University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Dukuray","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jz4aj89","id-type":"ROR","asserted-by":"publisher"}],"name":"Maastricht University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge van der","family":"Putten","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jz4aj89","id-type":"ROR","asserted-by":"publisher"}],"name":"Maastricht University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggie","family":"Paulus","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jz4aj89","id-type":"ROR","asserted-by":"publisher"}],"name":"Maastricht University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Al-Lahham","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jgpyd84","id-type":"ROR","asserted-by":"publisher"}],"name":"German Jordanian University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine A.P.G.","family":"van Mastrigt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jz4aj89","id-type":"ROR","asserted-by":"publisher"}],"name":"Maastricht University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"S0266462326103912_r26","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1874929"},{"key":"S0266462326103912_r58","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.078"},{"key":"S0266462326103912_r70","first-page":"686","article-title":"Cost-effectiveness of introducing the pneumococcal conjugate vaccine for children under 5 years in the Islamic Republic of Iran","volume":"25","author":"Ezoji","year":"2019","journal-title":"East Mediterr Health J.= La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit"},{"key":"S0266462326103912_r108","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.035"},{"key":"S0266462326103912_r12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003277"},{"key":"S0266462326103912_r52","doi-asserted-by":"publisher","DOI":"10.1186\/2191-1991-2-4"},{"key":"S0266462326103912_r16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14484-z"},{"key":"S0266462326103912_r34","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1246961"},{"key":"S0266462326103912_r8","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462317000526"},{"key":"S0266462326103912_r56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.047"},{"key":"S0266462326103912_r63","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1067351"},{"key":"S0266462326103912_r87","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.03.045"},{"key":"S0266462326103912_r104","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1708668"},{"key":"S0266462326103912_r17","first-page":"1","article-title":"Towards a multi-sectoral approach to population health: a scoping review of cross-sectoral evaluations of health interventions","author":"Koleva-Kolarova","year":"2026","journal-title":"Appl Health Econ Health Policy"},{"key":"S0266462326103912_r24","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30422-4"},{"key":"S0266462326103912_r35","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2025.2542285"},{"key":"S0266462326103912_r5","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-024-00552-1"},{"key":"S0266462326103912_r6","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00942-2"},{"key":"S0266462326103912_r81","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2046468"},{"key":"S0266462326103912_r92","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03277-3"},{"key":"S0266462326103912_r103","first-page":"179","article-title":"Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme","volume":"16","author":"Drost","year":"2013","journal-title":"J Ment Health Policy Econ"},{"key":"S0266462326103912_r99","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2345670"},{"key":"S0266462326103912_r44","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000438"},{"key":"S0266462326103912_r42","unstructured":"42. World Bank. Official exchange rate (LCU per US$, period average). World Bank Group. 2025. Available from: https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF."},{"key":"S0266462326103912_r69","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.015"},{"key":"S0266462326103912_r95","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1383668"},{"key":"S0266462326103912_r77","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00538-z"},{"key":"S0266462326103912_r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.004"},{"key":"S0266462326103912_r74","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.091"},{"key":"S0266462326103912_r21","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1894933"},{"key":"S0266462326103912_r91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.02.021"},{"key":"S0266462326103912_r96","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2445429"},{"key":"S0266462326103912_r97","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.011"},{"key":"S0266462326103912_r4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01526"},{"key":"S0266462326103912_r106","unstructured":"106. VIEW-hub. Pneumococcal conjugate vaccine (PCV). Johns Hopkins Bloomberg School of Public Health. 2025. Available from: https:\/\/view-hub.org\/vaccine\/pcv."},{"key":"S0266462326103912_r45","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462305050324"},{"key":"S0266462326103912_r72","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20200415"},{"key":"S0266462326103912_r88","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2245291"},{"key":"S0266462326103912_r102","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050498"},{"key":"S0266462326103912_r47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2509"},{"key":"S0266462326103912_r40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172414"},{"key":"S0266462326103912_r48","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2011.08.004"},{"key":"S0266462326103912_r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.10.006"},{"key":"S0266462326103912_r39","unstructured":"39. World Bank. World Bank country classifications by income level for 2024-2025. 2025. Available from: https:\/\/blogs.worldbank.org\/en\/opendata\/world-bank-country-classifications-by-income-level-for-2024-2025."},{"key":"S0266462326103912_r50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.111"},{"key":"S0266462326103912_r28","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0439-3"},{"key":"S0266462326103912_r71","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1560769"},{"key":"S0266462326103912_r37","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.3.014"},{"key":"S0266462326103912_r85","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2257426"},{"key":"S0266462326103912_r89","article-title":"Estimating the cost-effectiveness of switching to higher-valency pediatric pneumococcal conjugate vaccines in the United Kingdom","volume":"11","author":"Wilson","year":"2023","journal-title":"Vaccine"},{"key":"S0266462326103912_r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.088"},{"key":"S0266462326103912_r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.081"},{"key":"S0266462326103912_r38","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"S0266462326103912_r54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067324"},{"key":"S0266462326103912_r20","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-016-0224-7"},{"key":"S0266462326103912_r57","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29008"},{"key":"S0266462326103912_r68","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1438794"},{"key":"S0266462326103912_r2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0446-9"},{"key":"S0266462326103912_r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.11.056"},{"key":"S0266462326103912_r78","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7494965"},{"key":"S0266462326103912_r84","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010135"},{"key":"S0266462326103912_r23","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1409116"},{"key":"S0266462326103912_r90","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.002"},{"key":"S0266462326103912_r18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-878"},{"key":"S0266462326103912_r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.039"},{"key":"S0266462326103912_r93","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2400751"},{"key":"S0266462326103912_r94","article-title":"Cost-effectiveness analysis of routine childhood immunization with 20-valent versus 15-valent pneumococcal conjugate vaccines in Germany","volume":"12","author":"Huang","year":"2024","journal-title":"Vaccine"},{"key":"S0266462326103912_r100","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00977-4"},{"key":"S0266462326103912_r80","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060950"},{"key":"S0266462326103912_r101","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01067-1"},{"key":"S0266462326103912_r30","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00805-5"},{"key":"S0266462326103912_r10","unstructured":"10. World Health Organization. Pneumococcal Disease. WHO. 2025 Available from: https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/norms-and-standards\/vaccine-standardization\/pneumococcal-disease."},{"key":"S0266462326103912_r14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"S0266462326103912_r60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.043"},{"key":"S0266462326103912_r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906"},{"key":"S0266462326103912_r13","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1719588"},{"key":"S0266462326103912_r67","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2018.01.001"},{"key":"S0266462326103912_r64","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001587"},{"key":"S0266462326103912_r53","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jval.2011.11.013","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach","volume":"15","author":"Wu","year":"2012","journal-title":"Value Health"},{"key":"S0266462326103912_r79","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1870396"},{"key":"S0266462326103912_r46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-260"},{"key":"S0266462326103912_r73","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1701911"},{"key":"S0266462326103912_r3","first-page":"1","article-title":"Towards a broader assessment of value in vaccines: the BRAVE way forward","author":"Bell","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"key":"S0266462326103912_r61","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.051"},{"key":"S0266462326103912_r7","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-023-01658-8"},{"key":"S0266462326103912_r15","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2040989"},{"key":"S0266462326103912_r82","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2114252"},{"key":"S0266462326103912_r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2011.08.003"},{"key":"S0266462326103912_r98","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.12.057"},{"key":"S0266462326103912_r107","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.024"},{"key":"S0266462326103912_r19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400475111"},{"key":"S0266462326103912_r32","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1246960"},{"key":"S0266462326103912_r59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"S0266462326103912_r33","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1246962"},{"key":"S0266462326103912_r62","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001288"},{"key":"S0266462326103912_r66","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.070"},{"key":"S0266462326103912_r36","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1563"},{"key":"S0266462326103912_r43","doi-asserted-by":"publisher","DOI":"10.1332\/174426410X482999"},{"key":"S0266462326103912_r105","unstructured":"105. United Nations. Sustainable Development. United Nations. 2025. Available from: https:\/\/sdgs.un.org\/."},{"key":"S0266462326103912_r75","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1952869"},{"key":"S0266462326103912_r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.031"},{"key":"S0266462326103912_r41","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-021-00711-y"},{"key":"S0266462326103912_r55","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2013.03.052","article-title":"Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to the birth cohort in Japan","volume":"31","author":"S-l","year":"2013","journal-title":"Vaccine"},{"key":"S0266462326103912_r1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6267343"},{"key":"S0266462326103912_r65","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-016-0770-9"},{"key":"S0266462326103912_r76","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-007211"},{"key":"S0266462326103912_r86","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2184090"},{"key":"S0266462326103912_r83","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.12.004"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462326103912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:56:43Z","timestamp":1784296603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462326103912\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0266462326103912"],"URL":"https:\/\/doi.org\/10.1017\/s0266462326103912","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e59"}}